HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erich Minar Selected Research

Carotid Artery Diseases

2/2019The prognostic value of serum amyloid A for long-term mortality among patients with subclinical carotid atherosclerosis.
12/2016Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study.
8/2015The impact of selectins on mortality in stable carotid atherosclerosis.
2/2015The impact of uric acid on long-term mortality in patients with asymptomatic carotid atherosclerotic disease.
9/2012Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis.
7/2011Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
4/2011Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis.
1/2011The impact of dental disease on mortality in patients with asymptomatic carotid atherosclerosis.
4/2010Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
4/2007C-reactive protein predicts future cardiovascular events in patients with carotid stenosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erich Minar Research Topics

Disease

22Atherosclerosis
02/2019 - 07/2002
20Peripheral Arterial Disease
04/2018 - 02/2002
20Inflammation (Inflammations)
07/2011 - 06/2002
19Pathologic Constriction (Stenosis)
07/2017 - 04/2002
19Stroke (Strokes)
01/2014 - 01/2003
15Myocardial Infarction
01/2014 - 11/2003
15Thrombosis (Thrombus)
02/2009 - 12/2002
13Carotid Artery Diseases
02/2019 - 05/2005
12Venous Thrombosis (Deep-Vein Thrombosis)
01/2012 - 01/2002
12Venous Thromboembolism
08/2008 - 11/2002
11Carotid Stenosis (Carotid Artery Stenosis)
11/2019 - 01/2004
6Neoplasms (Cancer)
08/2008 - 11/2002
6Cardiovascular Diseases (Cardiovascular Disease)
02/2006 - 07/2002
5Pulmonary Embolism
01/2012 - 11/2002
5Hypertension (High Blood Pressure)
02/2006 - 02/2004
4Intermittent Claudication
03/2015 - 08/2004
4Ischemia
12/2009 - 05/2006
4Chronic Limb-Threatening Ischemia
05/2009 - 08/2004
4Diabetes Mellitus
07/2005 - 11/2002
3Hemorrhage
04/2018 - 02/2006
3Atherosclerotic Plaque (Atheroma)
08/2015 - 01/2003
3False Aneurysm (Pseudoaneurysm)
08/2010 - 02/2006
3Renal Artery Obstruction (Renal Artery Stenosis)
07/2009 - 02/2004
3Hyperlipidemias (Hyperlipidemia)
02/2006 - 11/2002
3Abdominal Aortic Aneurysm
09/2005 - 04/2002
3Soft Tissue Infections
02/2005 - 10/2003
2Peripheral Vascular Diseases (Peripheral Vascular Disease)
10/2013 - 05/2008
2Stable Angina
01/2011 - 06/2003
2Unstable Angina
01/2011 - 06/2003
2Transient Ischemic Attack
03/2008 - 11/2003
2Vascular Diseases (Vascular Disease)
09/2005 - 09/2003
2Coronary Artery Disease (Coronary Atherosclerosis)
08/2005 - 01/2005
2Ischemic Stroke
07/2005 - 01/2004
2Hypotension (Low Blood Pressure)
04/2005 - 10/2003
2Hyperplasia
01/2005 - 06/2004
2Aneurysm (Aneurysms)
12/2004 - 07/2002
2Hyperhomocysteinemia
01/2004 - 04/2003
1Non-ST Elevated Myocardial Infarction
01/2011
1Fistula
08/2010
1Activated Protein C Resistance (APC Resistance)
04/2009

Drug/Important Bio-Agent (IBA)

16C-Reactive ProteinIBA
02/2019 - 05/2002
12omega-Chloroacetophenone (Mace)IBA
11/2019 - 11/2003
7Prothrombin (Factor II)IBA
08/2008 - 01/2003
6Serum Amyloid A Protein (Serum Amyloid A)IBA
02/2019 - 06/2002
6fibrin fragment D (D-dimer)IBA
08/2010 - 01/2002
6Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
08/2008 - 11/2002
6Fibrinogen (Factor I)FDA Link
11/2005 - 06/2002
5nitinolIBA
10/2013 - 08/2004
5AnticoagulantsIBA
01/2012 - 06/2004
5Factor VIII (Coagulation Factor VIII)IBA
08/2008 - 04/2003
5Indicators and Reagents (Reagents)IBA
05/2007 - 07/2002
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2018 - 06/2003
4Thromboplastin (Tissue Factor)IBA
01/2011 - 01/2003
4AntithrombinsIBA
04/2009 - 01/2003
4Protein CIBA
04/2009 - 01/2003
4factor V LeidenIBA
01/2006 - 11/2002
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2006 - 07/2002
3Clopidogrel (Plavix)FDA Link
04/2018 - 07/2005
3Biomarkers (Surrogate Marker)IBA
07/2009 - 09/2004
3Lipoprotein(a)IBA
01/2007 - 07/2002
3Hemostatics (Antihemorrhagics)IBA
07/2006 - 08/2003
3CreatinineIBA
07/2006 - 01/2002
3lipoprotein-associated coagulation inhibitor (TFPI)IBA
10/2005 - 01/2003
2von Willebrand FactorIBA
11/2019 - 01/2003
2AntigensIBA
11/2019 - 02/2007
2edoxabanIBA
04/2018 - 04/2015
2Factor Xa InhibitorsIBA
04/2015 - 01/2012
2Complement System Proteins (Complement)IBA
09/2012 - 11/2005
2MetalsIBA
05/2009 - 02/2009
2Phenobarbital (Luminal)FDA Link
07/2007 - 08/2006
2dimethylarginineIBA
07/2006 - 04/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006 - 11/2005
2Protein SIBA
01/2006 - 06/2004
2AlbuminsIBA
05/2004 - 03/2004
2Serum AlbuminIBA
05/2004 - 03/2004
2Heme Oxygenase-1IBA
03/2004 - 04/2002
1Chewing Gum (Chewing Gums)IBA
07/2017
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2015
1E-SelectinIBA
08/2015
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2015
1SelectinsIBA
08/2015
1Uric Acid (Urate)IBA
02/2015
1Inflammation MediatorsIBA
09/2012
1Complement C5 (Complement 5)IBA
09/2012
1RivaroxabanIBA
01/2012
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2012
1Vitamin KFDA Link
01/2012
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
07/2011
1Messenger RNA (mRNA)IBA
01/2011
1Cystatin CIBA
04/2010

Therapy/Procedure

35Stents
10/2013 - 02/2002
18Therapeutics
04/2018 - 04/2003
11Percutaneous Coronary Intervention
01/2014 - 06/2003
7Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2014 - 11/2003
3Surgical Amputation (Amputations)
05/2011 - 06/2005
3Punctures
08/2006 - 04/2005
3Brachytherapy
07/2005 - 02/2004
3Carotid Endarterectomy
01/2004 - 05/2003
2Oral Hygiene (Dental Hygiene)
01/2011 - 09/2006
2Conservative Treatment
04/2005 - 04/2002